Range
1.96 - 2.3
Vol / Avg.
1.5M/1.2M
Div / Yield
-
52 Wk
0.8 - 3.68
Mkt Cap
50.8M
Payout Ratio
-
Open
2.14
P/E
-
EPS
-1.64
Shares
25.2M
Outstanding
25.2M
Total Float
20.8M
Benzinga - 19 minutes ago
Benzinga - 4 hours ago
Benzinga - 20 hours ago
Benzinga - 20 hours ago
Benzinga - Jun 10, 2021, 8:42AM
Benzinga - May 17, 2021, 5:19PM
Benzinga - Apr 9, 2021, 10:53AM
Benzinga - Apr 9, 2021, 8:01AM
Benzinga - Jan 20, 2021, 7:47AM
Benzinga - Jan 19, 2021, 10:59AM
Benzinga - Jan 19, 2021, 7:47AM
Benzinga - Dec 29, 2020, 9:27AM
load more
Sector: Health Care.Industry: Biotechnology
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-1.640
REV0
Q4 2020Est.ActualSurprise
EPS-0.180-0.600 -0.4200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TENXTenax Therapeutics6.17%50.8M

Tenax Therapeutics Frequently Asked Questions

Q

How do I buy Tenax Therapeutics (TENX) stock?

A

You can purchase shares of Tenax Therapeutics (NASDAQ: TENX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Tenax Therapeutics's (TENX) competitors?

A

Other companies in Tenax Therapeutics’s space includes: Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Synaptogenix (NASDAQ:SNPX), Cellectar Biosciences (NASDAQ:CLRB) and Brickell Biotech (NASDAQ:BBI).

Q

What is the target price for Tenax Therapeutics (TENX) stock?

A

The latest price target for Tenax Therapeutics (NASDAQ: TENX) was reported by HC Wainwright & Co. on December 29, 2020. The analyst firm set a price target for 5.00 expecting TENX to rise to within 12 months (a possible 147.86% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Tenax Therapeutics (TENX)?

A

The stock price for Tenax Therapeutics (NASDAQ: TENX) is $2.0173 last updated Today at 4:06:37 PM.

Q

Does Tenax Therapeutics (TENX) pay a dividend?

A

There are no upcoming dividends for Tenax Therapeutics.

Q

When is Tenax Therapeutics (NASDAQ:TENX) reporting earnings?

A
Tenax Therapeutics’s Q2 earnings are confirmed for after-market on August 16, 2021.
Q

Is Tenax Therapeutics (TENX) going to split?

A

There is no upcoming split for Tenax Therapeutics.

Q

What sector and industry does Tenax Therapeutics (TENX) operate in?

A

Tenax Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.